Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
1 April 1993 | Volume 118 Issue 7 | Pages 557-561
The introduction of penicillin 50 years ago was followed by an extraordinary period of discovery, exuberant use, and predictable obsolescence. Resistant bacterial strains have emerged and have spread throughout the world because of the remarkable genetic plasticity of the microorganisms, heavy selective pressures of use, and the mobility of the world population. New and more expensive drugs have appeared almost in the nick of time, but it is doubtful that they will keep pace. The problem of resistance to antimicrobial drugs is particularly troublesome in developing countries. The underlying problems are largely economic and societal, and no ready solutions are available. An urgent need exists for more appropriate selection and use of antimicrobial drugs in the developed as well as in developing countries. The focus in developing countries should be on the availability of safe and effective drugs and on the enforcement of more responsible national drug policies. These issues must be addressed by the collective action of governments, the pharmaceutical industry, health care providers, and consumers. The developed countries have an important stake in the ways in which antibiotics are used in developing countries because resistant microorganisms do not recognize national boundaries.
Author and Article Information
From The Ohio State University, Columbus, Ohio.
PERSPECTIVE
Resistance to Antimicrobial DrugsA Worldwide Calamity
![]()
Requests for Reprints: Calvin M. Kunin, MD, Department of Internal Medicine, The Ohio State University, Starling Loving Hall, Room M110, 320 West 10th Avenue, Columbus, OH 43210.
This article has been cited by other articles:
![]() |
J. Bishara, D. Hershkovitz, M. Paul, Z. Rotenberg, and S. Pitlik Appropriateness of antibiotic therapy on weekends versus weekdays J. Antimicrob. Chemother., September 1, 2007; 60(3): 625 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Masood, I. Moumoulidis, and J. Panesar Acute rhinosinusitis in adults: an update on current management Postgrad. Med. J., June 1, 2007; 83(980): 402 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Willemsen, A. Groenhuijzen, D. Bogaers, A. Stuurman, P. van Keulen, and J. Kluytmans Appropriateness of Antimicrobial Therapy Measured by Repeated Prevalence Surveys Antimicrob. Agents Chemother., March 1, 2007; 51(3): 864 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Raveh, E. Muallem-Zilcha, A. Greenberg, Y. Wiener-Well, Y. Schlesinger, and A.M. Yinnon Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem QJM, June 1, 2006; 99(6): 397 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Danelon, E. M. Nestorovich, M. Winterhalter, M. Ceccarelli, and S. M. Bezrukov Interaction of Zwitterionic Penicillins with the OmpF Channel Facilitates Their Translocation Biophys. J., March 1, 2006; 90(5): 1617 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Huang, L. Morlock, C.-H. Lee, L.-S. Chen, and Y.-J. Chou Antibiotic Prescribing for Children With Nasopharyngitis (Common Colds), Upper Respiratory Infections, and Bronchitis Who Have Health-Professional Parents Pediatrics, October 1, 2005; 116(4): 826 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mangione-Smith, M. N. Elliott, L. Wong, L. McDonald, and J. Roski Measuring the Quality of Care for Group A Streptococcal Pharyngitis in 5 US Health Plans Arch Pediatr Adolesc Med, May 1, 2005; 159(5): 491 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Huang, Y.-J. Chou, H.-J. Chang, M. Ho, and L. Morlock Antibiotic prescribing by ambulatory care physicians for adults with nasopharyngitis, URIs, and acute bronchitis in Taiwan: a multi-level modeling approach Fam. Pract., April 1, 2005; 22(2): 160 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Raebel Interventions to Improve Treatment of Respiratory Infections in Ambulatory Managed-Care Patients Ann. Pharmacother., April 1, 2005; 39(4): 699 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-R. Hsueh, L.-J. Teng, W.-H. Chen, H.-J. Pan, M.-L. Chen, S.-C. Chang, K.-T. Luh, and F.-Y. Lin Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus Causing Nosocomial Infections at a University Hospital in Taiwan from 1986 to 2001 Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1361 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Bucher, P. Tschudi, J. Young, P. Periat, A. Welge-Lussen, H. Zust, and C. Schindler Effect of Amoxicillin-Clavulanate in Clinically Diagnosed Acute Rhinosinusitis: A Placebo-Controlled, Double-blind, Randomized Trial in General Practice Arch Intern Med, August 11, 2003; 163(15): 1793 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gonzales A 65-Year-Old Woman With Acute Cough Illness and an Important Engagement JAMA, May 28, 2003; 289(20): 2701 - 2708. [Full Text] [PDF] |
||||
![]() |
J. Conly Antimicrobial resistance in Canada Can. Med. Assoc. J., October 15, 2002; 167(8): 885 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Varaldo Antimicrobial resistance and susceptibility testing: an evergreen topic J. Antimicrob. Chemother., July 1, 2002; 50(1): 1 - 4. [Full Text] [PDF] |
||||
![]() |
G. C. Velmahos, K. G. Toutouzas, G. Sarkisyan, L. S. Chan, A. Jindal, M. Karaiskakis, N. Katkhouda, T. V. Berne, and D. Demetriades Severe Trauma Is Not an Excuse for Prolonged Antibiotic Prophylaxis Arch Surg, May 1, 2002; 137(5): 537 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Osmon Antimicrobial Resistance: Guidelines for the Practicing Orthopaedic Surgeon J. Bone Joint Surg. Am., December 1, 2001; 83(12): 1891 - 1901. [Full Text] [PDF] |
||||
![]() |
D. Raveh, Y. Levy, Y. Schlesinger, A. Greenberg, B. Rudensky, and A.M. Yinnon Longitudinal surveillance of antibiotic use in the hospital QJM, March 1, 2001; 94(3): 141 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Pichichero Understanding Antibiotic Overuse for Respiratory Tract Infections in Children Pediatrics, December 1, 1999; 104(6): 1384 - 1388. [Full Text] |
||||
![]() |
J. Andrews, J. Ashby, G. Jevons, N. Lines, and R. Wise Antimicrobial resistance in Gram-positive pathogens isolated in the UK between October 1996 and January 1997 J. Antimicrob. Chemother., May 1, 1999; 43(5): 689 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gonzales, J. F. Steiner, A. Lum, and P. H. Barrett Jr Decreasing Antibiotic Use in Ambulatory Practice: Impact of a Multidimensional Intervention on the Treatment of Uncomplicated Acute Bronchitis in Adults JAMA, April 28, 1999; 281(16): 1512 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sehgal and J. P. Burke Combating Antimicrobial Resistance in India JAMA, March 24, 1999; 281(12): 1081 - 1082. [Full Text] [PDF] |
||||
![]() |
G. Pedersen, H. C. Schonheyder, F. H. Steffensen, and H. T. Sorenson Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemia J. Antimicrob. Chemother., January 1, 1999; 43(1): 119 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Colsky, R. S. Kirsner, and F. A. Kerdel Analysis of Antibiotic Susceptibilities of Skin Wound Flora in Hospitalized Dermatology Patients: The Crisis of Antibiotic Resistance Has Come to the Surface Arch Dermatol, August 1, 1998; 134(8): 1006 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kramer Management of the Young Febrile Child: A Commentary on Recent Practice Guidelines Pediatrics, July 1, 1997; 100(1): 128 - 128. [Full Text] [PDF] |
||||
![]() |
A. Tomasz Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University Workshop N. Engl. J. Med., April 28, 1994; 330(17): 1247 - 1251. [Full Text] |
||||